Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Solid Tumors
Clinical trial register · Australia

Solid Tumors Trials in Australia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3370 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:19 UTC
3370
Studies in scope
all four open statuses
1816
Recruiting now
open to new participants
776
Lead sponsors
across recruiting studies
Top sites
New Lambton Heights 1 Orange 1 Randwick 1 Bedford Park 1 Melbourne 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Incyte Corporation3 ORIC Pharmaceuticals2 EMD Serono Research & Development Institute, Inc.2 Gilead Sciences1 Arcus Biosciences, Inc.1 Apollomics Inc.1 Hoffmann-La Roche1 AstraZeneca1 GlaxoSmithKline1 Merck Sharp & Dohme LLC1 Fore Biotherapeutics1 Kivu Bioscience Inc.1 BeOne Medicines1 Pfizer1 PharmaEngine1 DualityBio Inc.1 Genentech, Inc.1 ABL Bio, Inc.1 Mirati Therapeutics Inc.1 ModernaTX, Inc.1 Clear sponsor filter
Site location
New Lambton Heights1 Orange1 Randwick1 Bedford Park1 Melbourne1
All 5 locations
Target enrolment
to

Solid Tumors trials in Australia

1 of 3370 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Fore Biotherapeutics
Phase 2
254
New Lambton Heights, Orange, Randwick, Bedford Park, Melbourne
2023-02-21
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-australia/condition/solid-tumors

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,370 studies in total at the last sync on 11 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies listing the condition Solid Tumors that also match the filters currently applied.

How many Solid Tumors trials are recruiting in Australia?

1 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Solid Tumors), 1 studies
PhaseStudiesRecruitingShare
Phase 211100%

Most active sponsors

Lead sponsors with the most studies (Solid Tumors)
Lead sponsorStudiesRecruiting
Fore Biotherapeutics11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.